[Pathologic changes in the cardiovascular system during treatment with glucocorticoid hormones].
D000818:Animals; D001161:Arteriosclerosis / Q000139:chemically induced; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001216:Asparagine / Q000378:metabolism; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002415:Cats; D002648:Child; D002675:Child, Preschool; D003327:Coronary Disease / Q000139:chemically induced; D003348:Cortisone / Q000009:adverse effects; D004151:Dipeptides / Q000378:metabolism; D004285:Dogs; D004790:Enzyme Induction / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects* / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D006973:Hypertension / Q000139:chemically induced; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008274:Magnesium / Q000378:metabolism; D009205:Myocarditis / Q000139:chemically induced; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D009404:Nephrotic Syndrome; D011188:Potassium / Q000378:metabolism; D011239:Prednisolone / Q000009:adverse effects; D011817:Rabbits; D051381:Rats; D012871:Skin Diseases / Q000188:drug therapy; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014221:Triamcinolone / Q000009:adverse effects
D004151:Dipeptides; D005938:Glucocorticoids; D014221:Triamcinolone; D001216:Asparagine; D012964:Sodium; D011239:Prednisolone; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D003348:Cortisone
Patologicheskie izmeneniia v serdechno-sosudistoĭ sisteme pri lechenii gliukokortikoidnymi gormonami.